En Xu

机构：Jiangsu University, Fujian Medical University, Second Affiliated Hospital of Guangzhou Medical University, Affiliated Hospital of Jiangsu University, China Shenhua Energy (China), Fujian Agriculture and Forestry University, Xi'an Jiaotong University, Guangzhou Medical University, Mississippi State University · ORCID：0000-0003-4874-6373

发表论文 93 篇 · 总被引 7256 次 · h-index 34

代表论文

• Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China (2025 · The Lancet · 被引 35)
• A20 negatively regulates necroptosis-induced microglia/macrophages polarization and mediates cerebral ischemic tolerance via inhibiting the ubiquitination of RIP3 (2024 · Cell Death and Disease · 被引 17)
• Hypoxic Preconditioning Attenuates Neuroinflammation via Inhibiting NF-κB/NLRP3 Axis Mediated by p-MLKL after Transient Global Cerebral Ischemia (2023 · Molecular Neurobiology · 被引 13)
• Global burden and trends of common head and neck cancers between 1990 and 2021: findings from the Global Burden of Disease Study 2021 (2025 · BMC Oral Health · 被引 10)
• Fractalkine/CX3CR1 axis is critical for neuroprotection induced by hypoxic postconditioning against cerebral ischemic injury (2024 · Cell Communication and Signaling · 被引 10)
• Transplantation of hESCs-Derived Neural Progenitor Cells Alleviates Secondary Damage of Thalamus After Focal Cerebral Infarction in Rats (2023 · Stem Cells Translational Medicine · 被引 10)